|
|
Volumn 11, Issue 2, 2001, Pages 261-268
|
|
New anti-Mycobacterium agents: Recent advances in patent literature
a
|
|
Author keywords
Antituberculous drugs; Mycobacterium avium; Mycobacterium tuberculosis
|
|
Indexed keywords
2 OXAZOLIDINONE DERIVATIVE;
ACETIC ACID DERIVATIVE;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIMYCOBACTERIAL AGENT;
ANTISENSE OLIGONUCLEOTIDE;
AZITHROMYCIN;
BACTERIAL ANTIGEN;
BACTERIAL DNA;
BCG VACCINE;
CARBAMIC ACID DERIVATIVE;
CIPROFLOXACIN;
CLARITHROMYCIN;
ERYTHROMYCIN DERIVATIVE;
ERYTHRONOLIDE DERIVATIVE;
ETHAMBUTOL;
FURAN DERIVATIVE;
IMIDAZOLE DERIVATIVE;
ISONIAZID;
MEMBRANE LIPID;
NITROIMIDAZOLE DERIVATIVE;
OXAZOLIDINONE DERIVATIVE;
PHENAZINE DERIVATIVE;
PHENYL GROUP;
PYRAZINAMIDE;
PYRIDINE DERIVATIVE;
RIFABUTIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
UNINDEXED DRUG;
BCG VACCINATION;
CHEMOTHERAPY;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG STRUCTURE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MILIARY TUBERCULOSIS;
MORTALITY;
MYCOBACTERIOSIS;
MYCOBACTERIUM INTRACELLULARE AVIUM;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PATENT;
REVIEW;
TUBERCULOSIS;
TUBERCULOSIS CONTROL;
|
|
EID: 0035154263
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.11.2.261 Document Type: Review |
|
Times cited : (5)
|
|
References (16)
|
